Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing.
Computational Biology
/ methods
Gene Rearrangement
Genes, bcl-2
/ genetics
Genes, myc
/ genetics
High-Throughput Nucleotide Sequencing
/ methods
Humans
In Situ Hybridization, Fluorescence
/ methods
Lymphoma, B-Cell
/ diagnosis
Lymphoma, Non-Hodgkin
/ diagnosis
Paraffin Embedding
/ methods
Proto-Oncogene Proteins c-bcl-6
/ genetics
Reproducibility of Results
Retrospective Studies
Sensitivity and Specificity
Tissue Fixation
/ methods
Translocation, Genetic
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
07 06 2021
07 06 2021
Historique:
received:
04
12
2020
accepted:
10
05
2021
entrez:
8
6
2021
pubmed:
9
6
2021
medline:
29
6
2021
Statut:
epublish
Résumé
In routine diagnostic pathology, cancer biopsies are preserved by formalin-fixed, paraffin-embedding (FFPE) procedures for examination of (intra-) cellular morphology. Such procedures inadvertently induce DNA fragmentation, which compromises sequencing-based analyses of chromosomal rearrangements. Yet, rearrangements drive many types of hematolymphoid malignancies and solid tumors, and their manifestation is instructive for diagnosis, prognosis, and treatment. Here, we present FFPE-targeted locus capture (FFPE-TLC) for targeted sequencing of proximity-ligation products formed in FFPE tissue blocks, and PLIER, a computational framework that allows automated identification and characterization of rearrangements involving selected, clinically relevant, loci. FFPE-TLC, blindly applied to 149 lymphoma and control FFPE samples, identifies the known and previously uncharacterized rearrangement partners. It outperforms fluorescence in situ hybridization (FISH) in sensitivity and specificity, and shows clear advantages over standard capture-NGS methods, finding rearrangements involving repetitive sequences which they typically miss. FFPE-TLC is therefore a powerful clinical diagnostics tool for accurate targeted rearrangement detection in FFPE specimens.
Identifiants
pubmed: 34099699
doi: 10.1038/s41467-021-23695-8
pii: 10.1038/s41467-021-23695-8
pmc: PMC8184748
doi:
Substances chimiques
BCL6 protein, human
0
Proto-Oncogene Proteins c-bcl-6
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3361Références
Genome Biol. 2020 Mar 23;21(1):73
pubmed: 32293513
Mod Pathol. 2019 May;32(5):609-620
pubmed: 30459475
Nucleic Acids Res. 2018 Sep 6;46(15):e91
pubmed: 29800273
Cancer Sci. 2014 Apr;105(4):437-44
pubmed: 24450488
J Clin Oncol. 2019 Dec 10;37(35):3359-3368
pubmed: 31498031
Lung Cancer. 2020 Feb;140:46-54
pubmed: 31862577
Blood. 2015 Nov 26;126(22):2466-74
pubmed: 26373676
Nat Methods. 2009 Nov;6(11):837-42
pubmed: 19820713
Nat Commun. 2018 Nov 29;9(1):4938
pubmed: 30498195
Nature. 2007 Aug 23;448(7156):959-63
pubmed: 17713539
Ann Oncol. 2019 Nov 1;30(Suppl_8):viii16-viii22
pubmed: 31738428
Blood. 2018 May 3;131(18):2060-2064
pubmed: 29475959
Am J Clin Pathol. 2020 Feb 8;153(3):353-359
pubmed: 31872861
Mol Cell Oncol. 2014 Jul;1(1):
pubmed: 26203462
Science. 2002 Feb 15;295(5558):1306-11
pubmed: 11847345
Nat Biotechnol. 2014 Oct;32(10):1019-25
pubmed: 25129690
EBioMedicine. 2016 Dec;14:55-64
pubmed: 27916548
J Mol Diagn. 2019 May;21(3):375-383
pubmed: 30605765
Cancer Med. 2019 Dec;8(18):7556-7566
pubmed: 31651105
Nat Methods. 2012 Oct;9(10):969-72
pubmed: 22961246
Hematol Oncol. 2020 Apr;38(2):171-180
pubmed: 31955451
Methods. 2020 Jan 1;170:17-32
pubmed: 31351925
Nature. 2020 Feb;578(7793):112-121
pubmed: 32025012
Nat Genet. 2018 Oct;50(10):1388-1398
pubmed: 30202056
Trends Genet. 2016 Sep;32(9):530-542
pubmed: 27478068
Hum Mol Genet. 1992 Nov;1(8):625-32
pubmed: 1301171
Bioinformatics. 2018 Jan 15;34(2):338-345
pubmed: 29048467
Mod Pathol. 2020 Jul;33(7):1350-1359
pubmed: 32047232
Epigenetics Chromatin. 2014 Jun 16;7:10
pubmed: 25031611
Blood. 2019 Jan 24;133(4):377-380
pubmed: 30510084
Blood Adv. 2018 Oct 23;2(20):2755-2765
pubmed: 30348671
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
Genome Biol. 2017 Jun 27;18(1):125
pubmed: 28655341
Blood. 2003 Aug 15;102(4):1443-8
pubmed: 12738680
Histopathology. 2013 Sep;63(3):418-24
pubmed: 23795946
Genome Res. 2011 Apr;21(4):505-14
pubmed: 21393386
Genes Chromosomes Cancer. 2012 Apr;51(4):338-43
pubmed: 22420028
Leuk Lymphoma. 2017 May;58(5):1037-1051
pubmed: 27678023